ArticleRheumatology and therapy2022

Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled Trials.

Martin Bergman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.